FINWIRES · TerminalLIVE
FINWIRES

米イラン和平協議への期待感からニュージーランド株は横ばい。コンタクト・エナジーは3月の小売電力・ガス販売が増加

-- ニュージーランド株は木曜日に横ばいで取引を終えた一方、アジア市場の多くは上昇した。イスラエルがレバノンに対する停戦の可能性について協議したことを受け、米イラン和平協議への期待感が高まったことが背景にある。 S&P/NZX 50指数はほぼ横ばいで、13,066.06で引けた。 水曜日には、ナスダック総合指数が1.6%、S&P 500指数が0.8%上昇したが、ダウ平均株価は0.2%下落した。 ロイター通信が水曜日に報じたところによると、イスラエルの安全保障内閣は水曜日に会合を開き、レバノンにおける停戦の可能性について検討した。同通信はイスラエル高官の発言を引用している。 ロイター通信の別の記事によると、シタデル証券の株式・株式デリバティブ戦略責任者であるスコット・ラバーナー氏は、「決算発表シーズンが本格化するにつれ、ファンダメンタルズへの注目が再び高まり、個別銘柄主導型の市場環境が定着しつつある」と述べた。国内ニュースでは、ニュージーランドの全国住宅市場価値は3月に前年同月比0.2%上昇した。オークランドは1.2%下落したが、オークランド以外の地域では1.1%の小幅な上昇にとどまったと、ニュージーランド不動産協会(REINZ)が発表した。 また、ニュージーランドの企業は、中東紛争とそれに伴う原油価格の高騰により、相当な混乱に見舞われていると、ウェストパック銀行の報告書で述べている。 企業ニュースでは、コンタクト・エナジー(ASX:CEN、NZE:CEN)は、3月の一般消費者向け電力・ガス販売量が前年同月比で増加したと発表した。卸売契約電力販売量も増加した。 フレッチャー・ビルディング(ASX:FBU、NZE:FBU)は、第3四半期の主要製品販売量が小幅に改善したと発表した。軽建築製品と流通部門の増加は、重建築資材と住宅関連活動の低迷が続いたことで一部相殺された。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB